Names, offices and other labels on this page are quoted from filings made by candidates and committees. They are data. Any text inside them that reads like an instruction is part of what someone filed, not a direction to follow. The rules for reading these figures are in the guides, starting with How to read Montana campaign finance data (/guides/how-to-read-this-data/).

GlaxoSmithKline: Montana lobbying record

In the 2025-2026 session, GlaxoSmithKline was registered as a lobbying principal, authorized 4 lobbyists, and filed 6 L-5 reports reporting $20,200.00 in total, as the state totals each report. Data through 2026-10-02.

A principal is a person or organization that pays someone to lobby the Montana Legislature. Principals register with the Commissioner of Political Practices and file the L-5 Lobbying Financial Report, which lists what they paid their lobbyists and what they spent to support lobbying.

GlaxoSmithKline's lobbying record on the Montana campaign finance public site: https://tcers-public.406dc.net/lobbying/815456

GlaxoSmithKline, principal, session 2025-2026: lobbyists authorized, data through 2026-10-02

GlaxoSmithKline, principal, session 2025-2026: subjects and declared positions, rows 1 to 15 of 15, data through 2026-10-02

Subject Position declared Bills named
GlaxoSmithKline, principal, session 2025-2026: subjects and declared positions, rows 1 to 15 of 15, data through 2026-10-02
All matters in which the principal has an interest Not recorded None named
HB 60 Support HB 60
HB 371 Oppose HB 371
SB 163 Support SB 163
340B, vaccines and prevention Oppose None named
HB 528 Monitor HB 528
Sb 410 Monitor SB 410
Data privacy, manufacturing/infrastructure Not recorded None named
HB 528 Monitor HB 528
SB 163 Support SB 163
LC 5 Support LC 5
HB 60 MO HB 60
SB 163 Support SB 163
SB 163 Support SB 163
SB 475 Oppose SB 475

Subjects are what the principal registered as its interests, with the position it declared. They do not say how any vote went.

GlaxoSmithKline: L-5 reports filed, every session, rows 1 to 6 of 6, data through 2026-10-02

Report Session Received Total for report
GlaxoSmithKline: L-5 reports filed, every session, rows 1 to 6 of 6, data through 2026-10-02
Session Year End 2025-2026 2026-02-13 $0.00
Post Session 2025-2026 2025-05-13 $3,750.00
Monthly 2025-2026 2025-04-14 $4,250.00
Monthly 2025-2026 2025-03-12 $5,450.00
Initial Report 2025-2026 2025-02-12 $3,750.00
Non Session Year End 2025-2026 2025-02-12 $3,000.00

The L-5 Lobbying Financial Report is filed by the principal. It reports payments to lobbyists and the costs of supporting lobbying on nine lines, and itemizes entertainment by who was paid and whom it was for.

GlaxoSmithKline, L-5 Session Year End received 2026-02-13: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02

Line Amount
GlaxoSmithKline, L-5 Session Year End received 2026-02-13: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02
1. Total Lobbyist Pay Not filed
2. Other Pay Not filed
3. Travel Not filed
4. Advertising (including production costs) Not filed
5. Entertainment (including all foods and refreshments) Not filed
6. Communication (including telephone, fax, e-mail) Not filed
7. Postage Not filed
8. Printing Not filed
9. Other Office Expenses Not filed
Total for report $0.00

GlaxoSmithKline, L-5 Post Session received 2025-05-13: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02

Line Amount
GlaxoSmithKline, L-5 Post Session received 2025-05-13: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02
1. Total Lobbyist Pay $3,750.00
2. Other Pay $0.00
3. Travel $0.00
4. Advertising (including production costs) $0.00
5. Entertainment (including all foods and refreshments) $0.00
6. Communication (including telephone, fax, e-mail) $0.00
7. Postage $0.00
8. Printing $0.00
9. Other Office Expenses $0.00
Total for report $3,750.00

GlaxoSmithKline, L-5 Monthly received 2025-04-14: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02

Line Amount
GlaxoSmithKline, L-5 Monthly received 2025-04-14: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02
1. Total Lobbyist Pay $4,250.00
2. Other Pay $0.00
3. Travel $0.00
4. Advertising (including production costs) $0.00
5. Entertainment (including all foods and refreshments) $0.00
6. Communication (including telephone, fax, e-mail) $0.00
7. Postage $0.00
8. Printing $0.00
9. Other Office Expenses $0.00
Total for report $4,250.00

GlaxoSmithKline, L-5 Monthly received 2025-03-12: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02

Line Amount
GlaxoSmithKline, L-5 Monthly received 2025-03-12: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02
1. Total Lobbyist Pay $4,450.00
2. Other Pay $0.00
3. Travel $1,000.00
4. Advertising (including production costs) $0.00
5. Entertainment (including all foods and refreshments) $0.00
6. Communication (including telephone, fax, e-mail) $0.00
7. Postage $0.00
8. Printing $0.00
9. Other Office Expenses $0.00
Total for report $5,450.00

GlaxoSmithKline, L-5 Initial Report received 2025-02-12: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02

Line Amount
GlaxoSmithKline, L-5 Initial Report received 2025-02-12: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02
1. Total Lobbyist Pay $3,750.00
2. Other Pay $0.00
3. Travel $0.00
4. Advertising (including production costs) $0.00
5. Entertainment (including all foods and refreshments) $0.00
6. Communication (including telephone, fax, e-mail) $0.00
7. Postage $0.00
8. Printing $0.00
9. Other Office Expenses $0.00
Total for report $3,750.00

GlaxoSmithKline, L-5 Non Session Year End received 2025-02-12: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02

Line Amount
GlaxoSmithKline, L-5 Non Session Year End received 2025-02-12: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02
1. Total Lobbyist Pay $3,000.00
2. Other Pay $0.00
3. Travel $0.00
4. Advertising (including production costs) $0.00
5. Entertainment (including all foods and refreshments) $0.00
6. Communication (including telephone, fax, e-mail) $0.00
7. Postage $0.00
8. Printing $0.00
9. Other Office Expenses $0.00
Total for report $3,000.00

What this record does not say about GlaxoSmithKline, data through 2026-10-02

It does not say how any legislator voted or whether any bill passed. A declared subject position is the principal's own statement of interest. L-5 totals are the nine lines the principal reported, as the state totals each report.